1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
BioCube, Inc.

BioCube, Inc.

BICB
BioCube, Inc.US flagOther OTC
0.00
USD
- -
- -
9,674.00Market Cap
2006 Y
2007 Y
2008 Y
2009 Y
2011 Y
2012 Y
2013 Y
TTM
Revenue per Share
0.08
0.17
8.22
26.06
- -
- -
- -
- -
Basic EPS, GAAP
- -
-0.01
-3.71
-2.33
-0.04
- -
-0.02
-0.02
Free Cash Flow per Basic Share
0.01
-0.02
-3.02
0.35
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.01
-3.69
-5.56
-0.05
-0.04
-0.06
-0.06
Tangible Book Value per Share
- -
-0.01
1.02
-0.64
-0.04
-0.03
-0.04
-0.04
Basic Weighted Avg Shares
3
3
1
2
25
29
31
40
Sales/Revenue/Turnover
- -
1
12
45
- -
- -
- -
- -
Operating Margin (%)
-3.06
-6.8
-41.56
-6.9
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
-6
-4
-1
- -
-1
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-3.41
-6.29
-45.05
-8.93
- -
- -
- -
- -
Working Capital
- -
- -
1
-2
-1
-1
-1
-2
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
2
-1
-1
-1
-1
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jan'13
Apr'14
Jul'14
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
45
45
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Jan'13
Apr'14
Jul'14
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
2
Payables & Accruals
- -
- -
- -
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-998.28%
20.56%
Free Cash Flow
- -
1,453.55%
430.6%
Net Income, GAAP
- -
3,318.89%
735.06%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
0.01
-0.01
- -
- -
- -
2013
- -
- -
-0.01
- -
-0.02
2014
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Paul Lisak
Full Time Employees
18
Sector
Financial Services
Industry
Shell Companies
Address
1531 Smithtown Avenue Bohemia NY United States of America 11716
IPO Date
Sep 5, 2007
CIK
0001374135
Website
biocubeinc.com
Similar Companies
Omega Alpha SPAC (OMEG)
Gores Holdings VIII, Inc. (GIIXW)
TZP Strategies Acquisition Corp. (TZPSU)
Nouveau Life Pharmaceuticals, Inc. (NOUV)
INSU Acquisition Corp. III (IIII)
Supernova Partners Acquisition Company, Inc. (SPNV-UN)
Business
BioCube, Inc. (BICB) is a development-stage company focused on the development and marketing of lithium ion batteries in North America; the company previously engaged in marketing devices for tetrahydrocannabinol and marijuana detection, industrial and environmental monitoring, and homeland security solutions. Headquartered at 1531 Smithtown Avenue in Bohemia, New York, BioCube, Inc. operates primarily in the electrical components and equipment industry within the capital goods sector, targeting North American markets with its battery technologies. Founded prior to its public listing in August 2009 and formerly known as Alliance Network Communications Holdings, Inc., the company changed its name to BioCube, Inc. in December 2010, with Paul Lisak serving as chairman, chief executive officer, and chief financial officer. In a significant recent development effective June 28, 2025, BioCube, Inc. underwent a change in control involving a merger with BioCube Inc., a California corporation, and related agreements for the transfer of entities including A-Bold Trading, alongside the acquisition of substantial preferred stock positions through PatientTrac Limited, marking a strategic reorganization and expansion under new control group leadership.